家庭非侵入性通气降低严重慢性阻塞性肺疾病患者的住院率和医疗费用
Home non-invasive ventilation reduces hospitalizations, and healthcare costs in adult patients with severe chronic obstructive pulmonary disease
一项回顾性队列研究分析了6家捷克健康保险公司2017-2022年间的数据,共867名≥18岁患有严重慢性阻塞性肺疾病的患者。研究发现,非侵入性通气与较低的死亡率(调整后HR=0.55)和住院天数相关,且住院费用降低。
- Article
- Open access
- Published: 05 November 2026
- Ondrej Gajdos1,
- Ondrej Zela2,
- Gleb Donin1,
- Martin Rozanek1,
- Martina Hola1,
- Ales Tichopad1,
- Milan Sova4,
- Jaroslav Lnenicka5 &
- …
- Samuel Genzor3
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Chronic hypercapnic respiratory failure decreases both life quality and expectancy in patients with severe chronic obstructive pulmonary disease. Home non-invasive ventilation (HNIV) support might be an effective option to improve their unfavourable prognosis. This retrospective cohort study used data from six Czech health insurance companies (covering 44% of the population) from 2017 to 2022. It included patients ≥ 18 years with COPD and chronic respiratory failure hospitalized during the study period. Exclusion criteria were dementia, prior HNIV treatment, death in 90 days after hospital discharge. Patients were divided into HNIV treatment and control groups. Propensity score matching was used to balance treatment groups. Mortality was assessed using Cox proportional hazards models, and hospitalization counts were analyzed using negative binomial regression accounting for individual follow-up time. The study analyzed 867 patients, with 396 meeting the inclusion criteria. After propensity score matching, the first selection included 192 patients (64 HNIV, 128 comparators), and the second selection included 144 patients (48 early HNIV, 96 comparators). HNIV was associated with a significantly lower risk of death (adjusted HR = 0.55; 95% CI, 0.31–0.99; p = 0.046). Two-year Kaplan–Meier mortality was 24.0% with HNIV versus 34.7% without HNIV. Although the unadjusted annualized hospitalization rate was lower with HNIV, the adjusted difference in admission counts was not statistically significant (IRR for comparators vs. HNIV = 1.50; 95% CI, 0.94–2.40; p = 0.087), while inpatient days were significantly lower with HNIV. Early HNIV was also associated with lower mortality (adjusted HR = 0.43; 95% CI, 0.21–0.86). HNIV was associated with lower mortality and fewer inpatient days in patients with severe COPD and chronic respiratory failure. Hospitalization costs were lower in the HNIV groups, although the differences were not statistically significant.
Abbreviations
- BMI:
-
Body mass index
- CCI:
-
Charlson Comorbidity Index
- CI:
-
Confidence interval
- COPD:
-
Chronic obstructive pulmonary disease
- CRF:
-
Chronic respiratory failure
- CZK:
-
Czech koruna
- HNIV:
-
Home non-invasive ventilation
- HR:
-
Hazard ratio
- HRQL:
-
Health-related quality of life
- ICD:
-
10-International Classification of Diseases, 10th Revision
- IQR:
-
Interquartile range
- IRR:
-
Incidence rate ratio
- KM:
-
Kaplan–Meier
- PSM:
-
Propensity score matching
- SD:
-
Standard deviation
- SMD:
-
Standardized mean difference
Acknowledgements
Not applicable.
Funding
This work was supported by the Grant Agency of the Czech Technical University in Prague, grant No. SGS24/153/OHK5/3T/17 and Ministry of Health of the Czech Republic research grant (NW25J-01-00013).
Author information
Authors and Affiliations
Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Prague, Czech Republic
Ondrej Gajdos, Gleb Donin, Martin Rozanek, Martina Hola & Ales Tichopad
Department of Pulmonology, Hospital Frydek-Mistek, Frýdek-Místek, Czech Republic
Ondrej Zela
Department of Respiratory Medicine, Faculty of Medicine, Palacky University in Olomouc, Olomouc, Czech Republic
Samuel Genzor
Department of Pulmonary Diseases and Tuberculosis, Faculty of Medicine, Masaryk University in Brno, Brno, Czech Republic
Milan Sova
Department of Pulmonology, Teaching Hospital Bulovka in Prague, Prague, Czech Republic
Jaroslav Lnenicka
Authors
- Ondrej Gajdos
- Ondrej Zela
- Gleb Donin
- Martin Rozanek
- Martina Hola
- Ales Tichopad
- Milan Sova
- Jaroslav Lnenicka
- Samuel Genzor
Corresponding author
Correspondence to Samuel Genzor.
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
All methods were carried out in accordance with relevant guidelines and regulations. The study was based exclusively on anonymized administrative health insurance claims data and involved no intervention in patient care. The need for a formal ethical review was discussed with the Ethics Committee of the Faculty of Biomedical Engineering at the Czech Technical University, which issued an official waiver confirming that ethical approval of the study and informed consent from participants was not required for this type of study (decision date: November 18, 2024).
Consent for publication
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Gajdos, O., Zela, O., Donin, G. et al. Home non-invasive ventilation reduces hospitalizations, and healthcare costs in adult patients with severe chronic obstructive pulmonary disease. Sci Rep (2026). https://doi.org/10.1038/s41598-026-79561-4
Received: 19 December 2025
Accepted: 02 November 2026
Published: 05 November 2026
DOI: https://doi.org/10.1038/s41598-026-79561-4
Keywords
来源:Nature 健康护理主题 · nature.com